1. Home
  2. BWAY vs JRVR Comparison

BWAY vs JRVR Comparison

Compare BWAY & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • JRVR
  • Stock Information
  • Founded
  • BWAY 2003
  • JRVR 2002
  • Country
  • BWAY Israel
  • JRVR Bermuda
  • Employees
  • BWAY 120
  • JRVR N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • JRVR Property-Casualty Insurers
  • Sector
  • BWAY Health Care
  • JRVR Finance
  • Exchange
  • BWAY Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • BWAY 245.2M
  • JRVR 261.1M
  • IPO Year
  • BWAY 2019
  • JRVR 2005
  • Fundamental
  • Price
  • BWAY $12.95
  • JRVR $5.53
  • Analyst Decision
  • BWAY Strong Buy
  • JRVR Buy
  • Analyst Count
  • BWAY 2
  • JRVR 4
  • Target Price
  • BWAY $14.25
  • JRVR $6.06
  • AVG Volume (30 Days)
  • BWAY 55.0K
  • JRVR 232.9K
  • Earning Date
  • BWAY 08-05-2025
  • JRVR 08-04-2025
  • Dividend Yield
  • BWAY N/A
  • JRVR 0.72%
  • EPS Growth
  • BWAY N/A
  • JRVR N/A
  • EPS
  • BWAY 0.08
  • JRVR N/A
  • Revenue
  • BWAY $43,457,000.00
  • JRVR $678,788,000.00
  • Revenue This Year
  • BWAY $351.53
  • JRVR $1.95
  • Revenue Next Year
  • BWAY $21.84
  • JRVR $6.80
  • P/E Ratio
  • BWAY $64.24
  • JRVR N/A
  • Revenue Growth
  • BWAY 26.86
  • JRVR N/A
  • 52 Week Low
  • BWAY $5.72
  • JRVR $3.00
  • 52 Week High
  • BWAY $13.66
  • JRVR $8.99
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 65.31
  • JRVR 46.25
  • Support Level
  • BWAY $12.76
  • JRVR $5.50
  • Resistance Level
  • BWAY $13.66
  • JRVR $5.73
  • Average True Range (ATR)
  • BWAY 0.50
  • JRVR 0.16
  • MACD
  • BWAY 0.02
  • JRVR -0.06
  • Stochastic Oscillator
  • BWAY 77.26
  • JRVR 9.18

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

Share on Social Networks: